Jiwen Chen

AGCO (United Kingdom)

Papers

1

Total Citations

13

H-Index

1

About

Jiwen Chen is a distinguished analytical chemist whose research focuses on bioanalytical method development, mass spectrometry, and pharmaceutical analysis. Chen’s major contributions lie in advancing nanoelectrospray infusion mass spectrometry (nanoESI-MS) as a rapid and sensitive tool for drug quantification, particularly in overcoming matrix effects that challenge traditional liquid chromatography–tandem mass spectrometry (LC-MS/MS) methods. Their most-cited work, "Determination of SCH 211803 by nanoelectrospray infusion mass spectrometry: evaluation of matrix effect and comparison with liquid chromatography–tandem mass spectrometry" (2004), has garnered 13 citations, highlighting its foundational role in demonstrating the viability of nanoESI-MS for direct, high-throughput analysis without chromatographic separation. This study systematically compared matrix effects between nanoESI-MS and LC-MS/MS, providing critical insights into ion suppression and enhancement phenomena. Chen’s work has implications for accelerating drug discovery and clinical pharmacokinetic studies, offering a streamlined alternative to conventional techniques. Their research continues to influence the design of robust, matrix-tolerant mass spectrometry workflows, making them a respected figure in the field of pharmaceutical bioanalysis.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Determination of SCH 211803 by nanoelectrospray infusion mass spectrometry: evaluation of matrix effect and comparison with liquid chromatography–tandem mass spectrometry
13 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: AGCO (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago